{
    "body_text": [
        {
            "endOffset": 11874,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In low income countries, malnutrition manifesting as failure to thrive is more common [2\u20137].",
            "startOffset": 11782,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 56339,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "Any publication of data on Failure to Thrive should include a detailed description of the methods used for data collection and analysis as possible.",
            "startOffset": 56191,
            "title": "Data presentation"
        },
        {
            "endOffset": 25994,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Growth data can therefore be inaccurate due to a number of factors including;",
            "startOffset": 25917,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26089,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "deficiencies in the technical aspects of weighing and charting, and interpreting growth charts",
            "startOffset": 25995,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 34263,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "A family history of constitutional delay in parents or siblings may point to the diagnosis.",
            "startOffset": 34172,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 54115,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Data on Failure to Thrive obtained from subjects receiving a vaccine should be compared with those obtained from an appropriately selected and documented control group(s) to assess background rates of hypersensitivity in non-exposed populations, and should be analysed by study arm and dose where possible, e.g. in prospective clinical trials.",
            "startOffset": 53772,
            "title": "Data analysis"
        },
        {
            "endOffset": 10706,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "These studies agreed that all current means of diagnosing FTT either over or under diagnose the condition and a more accurate diagnostic tool could be beneficial [1,2].",
            "startOffset": 10538,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 16376,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The difficulty in achieving a robust definition of FTT is due to both the limited number of available parameters to measure, and defining an abnormal change in these parameters given so much variability in normal patterns of growth in the first 12 months of life.",
            "startOffset": 16113,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 44145,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0050",
            "sentence": "Relation to the patient (e.g., immuniser [clinician, nurse], family member [indicate relationship], other).",
            "startOffset": 44038,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 36312,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0025",
            "sentence": "As mentioned in the overview paper, the case definition is accompanied by guidelines which are structured according to the steps of conducting a clinical trial, i.e. data collection, analysis and presentation.",
            "startOffset": 36103,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 40466,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weight for age deceleration through at least 2 centile spaces on growth chart",
            "startOffset": 40389,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 14504,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "An estimated 80 per cent of the world\u2019s 165 million stunted children live in just 14 countries.",
            "startOffset": 14409,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 46380,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Route and method of administration (e.g. intramuscular, intradermal, subcutaneous, and needle-free (including type and size), other injection devices).",
            "startOffset": 46229,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 20745,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "When one or more previous measurements are available, lack of weight gain in children, or evidence of weight loss in children or adults, is usually indicative of malnutrition.",
            "startOffset": 20570,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39847,
            "parents": [],
            "secId": "s0035",
            "sentence": "At least 2 weights, measured at least 4 weeks apart",
            "startOffset": 39796,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 43076,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0045",
            "sentence": "Guidelines numbers below have been developed to address data elements for the collection of adverse event information as specified in general drug safety guidelines by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ref), and the form for reporting of drug adverse events by the Council for International Organizations of Medical Sciences (ref).",
            "startOffset": 42656,
            "title": "Data collection"
        },
        {
            "endOffset": 48044,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Results of laboratory examinations, surgical and/or pathological findings and diagnoses if present.",
            "startOffset": 47945,
            "title": "The adverse event"
        },
        {
            "endOffset": 44035,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0050",
            "sentence": "Name and contact information of the investigator responsible for the subject, as applicable.",
            "startOffset": 43943,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 44586,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0060",
            "sentence": "Parental height and weight (both parents if known)",
            "startOffset": 44536,
            "title": "Demographics"
        },
        {
            "endOffset": 52202,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Not a case of Failure to Thrive",
            "startOffset": 52171,
            "title": "Data analysis"
        },
        {
            "endOffset": 10149,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Definitions of FTT typically incorporate both clinical characteristics of insufficient growth and specific anthropometric criteria which define it.",
            "startOffset": 10002,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 20569,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The International Classification of Diseases (ICD-10) defines Failure to thrive as the lack of expected normal physiological development and defines Malnutrition as \u201cThe degree of malnutrition is usually measured in terms of weight, expressed in standard deviations from the mean of the relevant reference population.",
            "startOffset": 20252,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 23148,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Beam balance scales are also widely used in clinical settings, and are considered more precise than hanging spring balances.",
            "startOffset": 23024,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 57873,
            "parents": [],
            "secId": "s0095",
            "sentence": "The findings, opinions and assertions contained in this consensus document are those of the individual scientific professional members of the working group.",
            "startOffset": 57717,
            "title": "Disclaimer"
        },
        {
            "endOffset": 29161,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "One hundred and fifty articles with potentially relevant material were reviewed in more detail, in order to identify studies using case definitions or, in their absence, providing clinical descriptions of the case material.",
            "startOffset": 28938,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 53453,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Analysis may also include other characteristics like qualitative patterns of criteria defining the event.",
            "startOffset": 53348,
            "title": "Data analysis"
        },
        {
            "endOffset": 55163,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "Data on possible Failure to Thrive events should be presented in accordance with data collection guidelines 1\u201324 and data analysis guidelines 31\u201336.",
            "startOffset": 55015,
            "title": "Data presentation"
        },
        {
            "endOffset": 52591,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "If few cases are reported, the concrete time course could be analysed for each; for a large number of cases, data can be analysed in the following increments:",
            "startOffset": 52433,
            "title": "Data analysis"
        },
        {
            "endOffset": 53149,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Whatever start and ending are used, they should be used consistently within and across study groups.",
            "startOffset": 53049,
            "title": "Data analysis"
        },
        {
            "endOffset": 22430,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The measurements of weight, length/height and MUAC, in combination with the infant\u2019s age and sex, gauge growth or failure to grow.",
            "startOffset": 22300,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 25665,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The desired outcome with the use of the WHO growth charts is to promote consistent practices in monitoring growth and assessing atypical patterns [40]",
            "startOffset": 25515,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 30463,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "These do not reflect clinical severity, rather how confident FTT can be diagnosed from the information available about the individual case being assessed (see below).",
            "startOffset": 30297,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 27580,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The increasing implementation of vaccination programs in pregnancy, and breadth of antenatal vaccine research in diverse healthcare settings where FTT is seen, makes the development of a definition able to be used in all of these settings urgent.",
            "startOffset": 27334,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 11781,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Under-nutrition or inadequate nutrition is thought to be the underlying factor with the consequence of significant interruption to the expected rate of growth, and is strongly linked to malnutrition.",
            "startOffset": 11582,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 16487,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "While many infants can be expected to track along their defined growth centile, some healthy infants will not.",
            "startOffset": 16377,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 24093,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In conjunction with growth charts, examination of clinical signs also determines a child who is failing to thrive.",
            "startOffset": 23979,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32073,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "In this way it is hoped that all possible cases of FTT can be captured.",
            "startOffset": 32002,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39506,
            "parents": [],
            "secId": "s0035",
            "sentence": "Infants with an undocumented birth date, where age is determined based on Mothers recall to nearest month",
            "startOffset": 39401,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 16113,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Existing case definitions for failure to thrive:",
            "startOffset": 16065,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32155,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Rationale for individual criteria or decisions made related to the case definition",
            "startOffset": 32073,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 44732,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0065",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 44626,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 45349,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0065",
            "sentence": "Any medication history (other than treatment for the event described) prior to, during, and after immunisation including prescription and non-prescription medication as well as medication or treatment with long half-life or long term effect.",
            "startOffset": 45108,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 45654,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0065",
            "sentence": "Maternal immunisation history (i.e. previous immunisations and any adverse event following immunisation (AEFI)), in particular occurrence of Failure to Thrive after a previous immunisation.",
            "startOffset": 45465,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 12148,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This gives no direct estimate of growth, only of attained weight and clinically children may deviate from their earlier centile position.",
            "startOffset": 12011,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 19021,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Body measurements in use include: weight; length in children under 24 months or under 87 cm in height; and mid-upper arm circumference (MUAC).",
            "startOffset": 18879,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37670,
            "parents": [],
            "secId": "s0035",
            "sentence": "Level 1 of diagnostic certainty",
            "startOffset": 37639,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 29398,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "This review resulted in a detailed summary of 70 articles, including information on the study type, the vaccine, the diagnostic criteria or case definition put forth, the time interval since time of immunisation, and any other symptoms.",
            "startOffset": 29162,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 41811,
            "parents": [],
            "secId": "s0040",
            "sentence": "The availability of information may vary depending upon resources, geographical region, and whether the source of information is a prospective clinical trial, a post-marketing surveillance or epidemiological study, or an individual report of Failure to Thrive.",
            "startOffset": 41551,
            "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
        },
        {
            "endOffset": 48179,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Outcome12 at last observation.",
            "startOffset": 48149,
            "title": "The adverse event"
        },
        {
            "endOffset": 34825,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Regression to the mean or \u201ccatch down growth\u201d may occur in large babies (for example macrosomic babies born to mothers with gestational diabetes) may involve periods of lower growth that crosses centiles, followed by steady growth along a lower centile.",
            "startOffset": 34572,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 11325,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Relevant clinical descriptors include child health, failure to thrive, growth interruption, growth retardation, weight/growth faltering, malnutrition, wasting, stunting and feeding disorder.",
            "startOffset": 11135,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 19203,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The nutritional indices commonly calculated for young children are:",
            "startOffset": 19136,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 30722,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Malnutrition/under-nutrition represents the most common cause of FTT globally.",
            "startOffset": 30644,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 25297,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The growth of preterm infants (less than 37 weeks) can be monitored using the WHO Child Growth Standards with measurements plotted using corrected postnatal age for prematurity (ie, postnatal age in weeks \u2212 [40 weeks \u2212 gestational age in weeks]) until 24 or 36 months of age.",
            "startOffset": 25022,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32491,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Pathology, radiology and laboratory findings may have a role in determining the cause of failure to thrive and its differential diagnoses, but do not form part of this case definition.",
            "startOffset": 32307,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37078,
            "parents": [],
            "secId": "s0035",
            "sentence": "For all levels of diagnostic certainty",
            "startOffset": 37040,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 47629,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Date/time of onset10, first observation11 and diagnosis12, end of episode13 and final outcome.14",
            "startOffset": 46786,
            "title": "The adverse event"
        },
        {
            "endOffset": 17497,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A delay in growth of head circumference is only affected in severe cases, demonstrating the need to follow growth parameters over time.",
            "startOffset": 17362,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33763,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Differentiation from other (similar/associated) disorders",
            "startOffset": 33706,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 56846,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "The search strategy in surveillance databases;",
            "startOffset": 56800,
            "title": "Data presentation"
        },
        {
            "endOffset": 25799,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Limitations of growth charts:",
            "startOffset": 25770,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 25916,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The basis of growth monitoring is measuring accurately, plotting on a growth chart and interpreting the growth curve.",
            "startOffset": 25799,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 31616,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "The number of symptoms and/or signs that will be documented for each case may vary considerably.",
            "startOffset": 31520,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35410,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Ideally, infants should be monitored regularly throughout their first 12 months to establish a true growth pattern and assess whether it is inadequate.",
            "startOffset": 35259,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 51727,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Level 2: Criteria as specified in the Failure to Thrive case definition",
            "startOffset": 51656,
            "title": "Data analysis"
        },
        {
            "endOffset": 48676,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Objective clinical evidence supporting classification of the event as \u201cserious\u201d.15",
            "startOffset": 48183,
            "title": "The adverse event"
        },
        {
            "endOffset": 28857,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The search resulted in the identification of 1296 references, limited to English language.",
            "startOffset": 28767,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 39317,
            "parents": [],
            "secId": "s0035",
            "sentence": "At least 2 weights, measured at least 4 weeks apart",
            "startOffset": 39266,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 40508,
            "parents": [],
            "secId": "s0035",
            "sentence": "Infants with no weight available",
            "startOffset": 40476,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 31727,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "The case definition has been formulated such that the Level 1 definition is highly specific for the condition.",
            "startOffset": 31617,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35059,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "However, this is a diagnosis made in retrospect typically, after the establishment of growth along the infant\u2019s \u201ctrue\u201d centile.",
            "startOffset": 34932,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 55878,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "The source of the denominator data should be reported and calculations of estimates be described (e.g. manufacturer data like total doses distributed, reporting through Ministry of Health, coverage/population based data, etc.).",
            "startOffset": 55651,
            "title": "Data presentation"
        },
        {
            "endOffset": 12312,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The growth curve of a normally growing child will represent gradual and incremental increases in weight from birth and is based on regular weight recordings [8,9].",
            "startOffset": 12149,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39604,
            "parents": [],
            "secId": "s0035",
            "sentence": "At least 2 weights, measured at least 4 weeks apart",
            "startOffset": 39553,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 45105,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0065",
            "sentence": "Maternal history of underlying diseases/disorders, gestational diabetes.",
            "startOffset": 45033,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 22822,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The most precise form of measurement is using an electronic scale, widely used in HIC.",
            "startOffset": 22736,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 11027,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Key anthropometric terms include child growth, growth assessment, growth chart monitoring, growth monitoring, and nutritional status.",
            "startOffset": 10894,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 14284,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The described prevalence depends mainly on the definition being used and the demographics of the population being studied, with higher rates occurring in economically disadvantaged rural and urban areas.",
            "startOffset": 14081,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 29657,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Very few used case definitions at all and no two studies used the same definition.",
            "startOffset": 29575,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 30187,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "The most common of these are malnutrition and under-nutrition, the most common causes of FTT worldwide.",
            "startOffset": 30084,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37792,
            "parents": [],
            "secId": "s0035",
            "sentence": "Infant age4 determined by a documented birth date",
            "startOffset": 37671,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 20252,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "One small study from Indian suggests a lower range of 110 mm for infants 1\u20136 months of age [32].",
            "startOffset": 20156,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 28188,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Following the process described in the overview paper [20] as well as on the Brighton Collaboration Website http://www.brightoncollaboration.org/internet/en/index/process.html, the Brighton Collaboration Failure to Thrive Working Group was formed in 2016 and included members of clinical, academic, public health and industry background.",
            "startOffset": 27851,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 15539,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In all settings there are a myriad of causes.",
            "startOffset": 15494,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 11581,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Anthropometric indices have been used universally for defining FTT, yet there is heterogeneity regarding the specific indices, for example weight for age versus weight for height/length.",
            "startOffset": 11395,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 30083,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "FTT is the most commonly used term to describe inadequate growth in infancy, however multiple terms exist, with aetiological descriptions often replacing FTT.",
            "startOffset": 29925,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 43638,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0050",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 43532,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 17265,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In practice, weight gain is the predominant indicator of choice.",
            "startOffset": 17201,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 21695,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "As such weight for age with a fall through two major centiles is used as the primary diagnostic measure.",
            "startOffset": 21591,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32524,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Timing post maternal immunisation",
            "startOffset": 32491,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 40385,
            "parents": [],
            "secId": "s0035",
            "sentence": "At least 2 weights, measured as least 4 weeks apart",
            "startOffset": 40334,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 51836,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Event does not meet case definition",
            "startOffset": 51801,
            "title": "Data analysis"
        },
        {
            "endOffset": 46782,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Clinical description of signs and symptoms of Failure to Thrive, and if there was medical confirmation of the event (i.e. patient seen by physician).",
            "startOffset": 46633,
            "title": "The adverse event"
        },
        {
            "endOffset": 15779,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Organic FTT-occurs in less than 5% of FTT cases-due to acute or chronic disorders that interfere with nutritional uptake such as cleft palate, malabsorption due to cystic fibrosis, and short gut syndrome.",
            "startOffset": 15575,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35258,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "FTT case definitions are limited by the difficulty in differentiating pathological FTT from the above conditions, especially in infancy when only limited time is available to observe growth patterns.",
            "startOffset": 35059,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39743,
            "parents": [],
            "secId": "s0035",
            "sentence": "Infant age determined by a documented birth date",
            "startOffset": 39695,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 50299,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "The following guidelines represent a desirable standard for analysis of data on Failure to Thrive to allow for comparability of data, and are recommended as an addition to data analysed for the specific study question and setting.",
            "startOffset": 50069,
            "title": "Data analysis"
        },
        {
            "endOffset": 18769,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It is useful as a screening tool for wasting and thinness, but is not recommended for children younger than 2 years as there has been little research on what BMI calculated from length means in infancy [28,29].",
            "startOffset": 18559,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 23537,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Centile charts are used and normal growth constitutes the tracking along the birth centile [5].",
            "startOffset": 23442,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 41469,
            "parents": [],
            "secId": "s0040",
            "sentence": "It was the consensus of the Brighton Collaboration Failure to Thrive Working Group to recommend the following guidelines to enable meaningful and standardised collection, analysis, and presentation of information about Failure to thrive.",
            "startOffset": 41232,
            "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
        },
        {
            "endOffset": 37286,
            "parents": [],
            "secId": "s0035",
            "sentence": "It is universally established that a diagnosis of failure to thrive should be based on anthropometric data.",
            "startOffset": 37179,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 45461,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0065",
            "sentence": "Maternal medication history during pregnancy.",
            "startOffset": 45416,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 45884,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Date and time of immunisation(s).",
            "startOffset": 45851,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 39126,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weight for age deceleration5 through at least 2 centile spaces on growth chart6",
            "startOffset": 37897,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 25515,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Breastfed infants born with low birth weight will be expected to track along the lower percentiles of the WHO charts because exclusive breastfeeding does not change the fact that they were small for age at birth [41].",
            "startOffset": 25298,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 46225,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "The anatomical sites (including left or right side) of all immunisations (e.g. vaccine A in proximal left lateral thigh, vaccine B in left deltoid).",
            "startOffset": 46077,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 30644,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Related term(s) of Failure to Thrive",
            "startOffset": 30608,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 25021,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The charts illustrate the way healthy children should grow and are considered to be the gold standard for assessing the growth of young children [37,40].",
            "startOffset": 24868,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 56983,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "The instrument of data collection (e.g. standardised questionnaire, diary card, report form);",
            "startOffset": 56890,
            "title": "Data presentation"
        },
        {
            "endOffset": 24689,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The WHO growth charts screen for possible abnormal or unhealthy growth.",
            "startOffset": 24618,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 14081,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In high income countries, the primary risks are preterm birth, and family dysfunction but in the majority of children with FTT an underlying medical condition is not found.",
            "startOffset": 13909,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42463,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0045",
            "sentence": "The guidelines are not intended to guide the primary reporting of Failure to Thrive to a surveillance system or study monitor.",
            "startOffset": 42337,
            "title": "Data collection"
        },
        {
            "endOffset": 13808,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Prevalence of FTT depends on risks within populations.",
            "startOffset": 13754,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 23979,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Signs indicative of poor weight gain for the neonate can include: a loss of more than 10% of birth weight in the first week, an average weight gain of less than 105 g per week or unexplained weight loss in infants 2 weeks to 3 months of age and poor weight gain compared to growth in length and head circumference [35].",
            "startOffset": 23660,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32882,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "That is, less than 12 month of age.",
            "startOffset": 32847,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 17111,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Healthy infants who may satisfy existing definitions of FTT include genetic short stature, preterm infants (if uncorrected for gestation), constitutional growth delay, and larger infants \u201cregressing to the mean\u201d [14].",
            "startOffset": 16894,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 27022,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A search of the US Vaccine Adverse Event Reporting System (VAERS) database (performed July 2016) described 47 reports where FTT was included in adverse event descriptions.",
            "startOffset": 26851,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 43940,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0050",
            "sentence": "Name and contact information of person reporting9 and/or diagnosing the Failure to Thrive as specified by country-specific data protection law.",
            "startOffset": 43659,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 39398,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weight for age deceleration through at least 2 centile spaces on growth chart",
            "startOffset": 39321,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 28766,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "To guide the decision-making for the case definition and guidelines, a literature search was performed using Medline, Embase and the Cochrane Libraries, including the terms infant, failure to thrive, growth retardation, growth failure, growth monitoring, growth faltering, under-nutrition and anthropometric.",
            "startOffset": 28458,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 45847,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded for both infant and mother (if immunized in pregnancy):",
            "startOffset": 45686,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 16065,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Mixed FTT-organic and non-organic causes can overlap [22\u201324]",
            "startOffset": 16005,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 17605,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Assessment of length is desirable to better track stunting and to assess aetiology of low weight [7,25,26].",
            "startOffset": 17498,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 27333,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This represents a missed opportunity, as data comparability is crucial to enable both systematic analysis of clinical trial safety as well as meaningful surveillance and investigation of adverse events reported in existing programs.",
            "startOffset": 27101,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37893,
            "parents": [],
            "secId": "s0035",
            "sentence": "At least 2 weights, measured at least 4 weeks apart",
            "startOffset": 37842,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 16893,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A 2007 review of seven FTT criteria applied to a Danish birth cohort of 6090 infants found low specificity, with 27% of infants meeting one or more criteria, with most single criteria identifying less than half of the infants with known significant under-nutrition [2].",
            "startOffset": 16624,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 43292,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0045",
            "sentence": "These data elements include an identifiable reporter and patient, one or more prior immunisations, and a detailed description of the adverse event, in this case, of Failure to Thrive following maternal immunisation.",
            "startOffset": 43077,
            "title": "Data collection"
        },
        {
            "endOffset": 44291,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0060",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 44185,
            "title": "Demographics"
        },
        {
            "endOffset": 46073,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Description of vaccine(s) (name of vaccine, manufacturer, lot number, dose (e.g. 0.25 mL, 0.5 mL, etc) and number of dose if part of a series of immunisations against the same disease).",
            "startOffset": 45888,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 54414,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "These guidelines represent a desirable standard for the presentation and publication of data on Failure to Thrive following maternal immunisation to allow for comparability of data, and are recommended as an addition to data presented for the specific study question and setting.",
            "startOffset": 54135,
            "title": "Data presentation"
        },
        {
            "endOffset": 12010,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Normal growth is described in reference to what is regarded as abnormal growth, falling below a pre-determined centile, usually the 3rd.",
            "startOffset": 11874,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 28458,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The composition of the working and reference group as well as results of the web-based survey completed by the reference group with subsequent discussions in the working group can be viewed at: http://www.brightoncollaboration.org/internet/en/index/working_groups.html.",
            "startOffset": 28189,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 36043,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Similarly assessment of vaccine causality in FTT is not dealt with in this guideline, however should be managed in accordance with recent WHO vaccine adverse event guideline [46].",
            "startOffset": 35864,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37387,
            "parents": [],
            "secId": "s0035",
            "sentence": "However no consensus exits as to which measurements achieve the highest specificity and sensitivity.",
            "startOffset": 37287,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 10894,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This paper focuses upon FTT in the first year of life, to assist the investigation of any potential concerns regarding reduced growth in infancy following antenatal maternal immunisation.",
            "startOffset": 10707,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 18395,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This definition may falsely include healthy infants who \u201cregress toward the mean\u201d while excluding infants with low weight where falling 2 major centiles is not possible [3,4,8,21].",
            "startOffset": 18215,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 24452,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Current assessment worldwide of FTT:",
            "startOffset": 24416,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39685,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weight for age deceleration through at least 2 centile spaces on growth chart",
            "startOffset": 39608,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 51870,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Additional categories for analysis",
            "startOffset": 51836,
            "title": "Data analysis"
        },
        {
            "endOffset": 13468,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It is predominately based on anthropometrical parameters but no consensus on the choice of anthropometric indices has been agreed upon nor the criteria for abnormality.",
            "startOffset": 13300,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 15254,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Children who are malnourished at 3\u20135 years of age often presented with anthropometric deficits at the end of their first year of life [19].",
            "startOffset": 15115,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 21864,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Infants with FTT who score falsely negative in the upper levels of certainty may still be diagnosed with FTT based on a weight for length ratio below the third centile.",
            "startOffset": 21696,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 13099,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Finally, there is little consensus as to what constitutes a normal rate of weight gain.",
            "startOffset": 13012,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 21462,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "As previously discussed, length/height is not well validated in the target population of infants up to 12 months of age.",
            "startOffset": 21342,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 23323,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Length is measured on a length board, infantometer, for a child less than 2 years old (less than 87 cm) in the recumbent position (crown-heel) measuring to the nearest 0.1 cm.",
            "startOffset": 23148,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 31379,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Thus, a clinically very severe event may appropriately be classified as Level 2 or 3 rather than Level 1 if it could reasonably be of non-FTT aetiology.",
            "startOffset": 31227,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 31520,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Detailed information about the severity of the event should additionally always be recorded, as specified by the data collection guidelines.",
            "startOffset": 31380,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42656,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0045",
            "sentence": "Investigators developing a data collection tool based on these data collection guidelines also need to refer to the criteria in the case definition, which are not repeated in these guidelines.",
            "startOffset": 42464,
            "title": "Data collection"
        },
        {
            "endOffset": 33358,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Instead, where feasible, details of this interval should be assessed and reported as described in the data collection guidelines.",
            "startOffset": 33229,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37639,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weight is generally regarded is the indicator of choice, particularly a change in growth velocity, and as such has been selected as the standard for this case definition with a weight for age deceleration as the primary indicator of failure to thrive.",
            "startOffset": 37388,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 51579,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Event meets case definition",
            "startOffset": 51552,
            "title": "Data analysis"
        },
        {
            "endOffset": 10001,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Failure to thrive (FTT) is a descriptive term for insufficient growth, usually identified in infancy.",
            "startOffset": 9900,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 12949,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Additionally, the well-recognized phenomenon of some healthy infants born above expected weight to experience an initial fall below birth centiles over the first 6\u201312 months, before following their \u201ccorrect\u201d centile, also known as \u2018regression to the mean\u2019, further complicates the specificity of FTT definitions based upon growth trajectory [12,13].",
            "startOffset": 12600,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 41153,
            "parents": [],
            "secId": "s0035",
            "sentence": "MUAC8 indicative of severe wasting",
            "startOffset": 40881,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 44455,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0060",
            "sentence": "Case/study participant identifiers (e.g. first name initial followed by last name initial) or code (or in accordance with country-specific data protection laws).",
            "startOffset": 44294,
            "title": "Demographics"
        },
        {
            "endOffset": 45032,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0065",
            "sentence": "Past medical history, including hospitalisations, underlying diseases/disorders, pre-immunisation signs and symptoms including identification of indicators for, or the absence of, a history of allergy to vaccines, vaccine components or medications; food allergy; allergic rhinitis; eczema; asthma.",
            "startOffset": 44735,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 19593,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "MUAC is also an important measure of wasting or acute malnutrition but is not an index by itself.",
            "startOffset": 19496,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32001,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "As maximum specificity normally implies a loss of sensitivity, two additional diagnostic levels have been included in the definition, offering a stepwise increase of sensitivity from Level 1 down to Level 3, while retaining an acceptable level of specificity at all levels.",
            "startOffset": 31728,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35670,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Finally, pathological FTT results from a variety of causes which are not dealt with in these guidelines.",
            "startOffset": 35566,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 15574,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Conventional classification of FTT:",
            "startOffset": 15539,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 30608,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Given the wide range of settings, equipment used, measurements taken and number of assessment time points, this is especially important for FTT.",
            "startOffset": 30464,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33228,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Therefore, to avoid selection bias, a restrictive time interval from immunisation to onset of FTT should not be an integral part of such a definition.",
            "startOffset": 33078,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39792,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weights obtained using a spring balance scale",
            "startOffset": 39747,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 50431,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Reported events should be classified in one of the following five categories including the three levels of diagnostic certainty.",
            "startOffset": 50303,
            "title": "Data analysis"
        },
        {
            "endOffset": 23441,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Growth charts are used to record a child\u2019s measurement against children of the same age and sex, a reference standard.",
            "startOffset": 23323,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 46408,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0070",
            "sentence": "Needle length and gauge.",
            "startOffset": 46384,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 30296,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "As with all Brighton Collaboration case definitions, the FTT definition presented includes differing levels.",
            "startOffset": 30188,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33706,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "In order to avoid selecting against such cases, the Brighton Collaboration case definition avoids setting arbitrary time frames.",
            "startOffset": 33578,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 52432,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "The interval between maternal immunisation and reported Failure to Thrive could be defined as the date/time of maternal immunisation to the date/time of onset8 of the first symptoms and/or signs consistent with the definition.",
            "startOffset": 52206,
            "title": "Data analysis"
        },
        {
            "endOffset": 55650,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "Although immunisation safety surveillance systems denominator data are usually not readily available, attempts should be made to identify approximate denominators.",
            "startOffset": 55487,
            "title": "Data presentation"
        },
        {
            "endOffset": 13754,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The literature acknowledges the lack of standardisation and recognizes that no one definition will be applicable or appropriate for all purposes but also acknowledges a need for clearly stated anthropometrical indices and cutoff points for the sake of scientific comparisons [3,15,16].",
            "startOffset": 13469,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 48145,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Treatment given for Failure to Thrive, especially specify what and dosing/duration if applicable.",
            "startOffset": 48048,
            "title": "The adverse event"
        },
        {
            "endOffset": 17746,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Using weight as the indicator FTT is described as a reduction in the expected rate of growth along an infant\u2019s previously defined curve [27].",
            "startOffset": 17605,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 22202,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The choice of measuring equipment, implementation and interpretation of measurements, and the common practices embedded in many cultures present significant challenges to establishing robust definitions for FTT [33].",
            "startOffset": 21986,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 31226,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "It needs to be re-emphasised that the grading of definition levels is entirely about diagnostic certainty, not clinical severity of an event.",
            "startOffset": 31085,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 54895,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "Additionally, it is recommended to refer to existing general guidelines for the presentation and publication of randomised controlled trials, systematic reviews, and meta-analyses of observational studies in epidemiology (e.g. statements of Consolidated Standards of Reporting Trials (CONSORT), of Improving the quality of reports of meta-analyses of randomised controlled trials (QUORUM), and of Meta-analysis Of Observational Studies in Epidemiology (MOOSE), respectively) [47].",
            "startOffset": 54415,
            "title": "Data presentation"
        },
        {
            "endOffset": 40263,
            "parents": [],
            "secId": "s0035",
            "sentence": "Infants with an undocumented birth date, where age is determined based on Mothers recall to nearest month",
            "startOffset": 40158,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 15883,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Non organic FTT-is attributed to inadequate intake with no apparent growth-inhibiting organic disorder.",
            "startOffset": 15780,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 23659,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There are no percentile lines between 0 and 2 weeks of age as it is difficult to assess the normal postnatal weight loss.",
            "startOffset": 23538,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 47674,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Concurrent signs, symptoms, and diseases.",
            "startOffset": 47633,
            "title": "The adverse event"
        },
        {
            "endOffset": 18214,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "An alternative definition of FTT is weight measurements that fall 2 major percentile lines between 2 or more time points.",
            "startOffset": 18093,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35863,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "These can be broadly grouped into one or more aetiological categories of poor oral nutrient intake, poor nutrient absorption, or increased caloric consumption (e.g. due to underlying disease).",
            "startOffset": 35671,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 53768,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "When only a small number of cases is presented, the respective values or time course can be presented individually.",
            "startOffset": 53653,
            "title": "Data analysis"
        },
        {
            "endOffset": 11134,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Aetiological literature attempting to define FTT includes the areas of malnutrition and feeding disorders.",
            "startOffset": 11028,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 27100,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There is no uniformly accepted definition of FTT in vaccine pharmacovigilance.",
            "startOffset": 27022,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 44486,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0060",
            "sentence": "Date of birth, age, and sex.",
            "startOffset": 44458,
            "title": "Demographics"
        },
        {
            "endOffset": 14408,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The UNICEF 2013 report states that globally, about one in four children under 5 years old are stunted from under-nutrition.",
            "startOffset": 14285,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 43497,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0045",
            "sentence": "The additional guidelines have been developed as guidance for the collection of additional information to allow for a more comprehensive understanding of Failure to Thrive following maternal immunisation.",
            "startOffset": 43293,
            "title": "Data collection"
        },
        {
            "endOffset": 56697,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "The type of surveillance (e.g. passive or active surveillance);",
            "startOffset": 56634,
            "title": "Data presentation"
        },
        {
            "endOffset": 58172,
            "parents": [],
            "secId": "s0095",
            "sentence": "Specifically, the findings and conclusions in this paper are those of the authors and do not necessarily represent the views of their respective institutions.",
            "startOffset": 58014,
            "title": "Disclaimer"
        },
        {
            "endOffset": 21022,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In the exceptional circumstances that no measurement of weight is available, reliance should be placed on clinical evidence\u201d [32].",
            "startOffset": 20892,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37178,
            "parents": [],
            "secId": "s0035",
            "sentence": "FTT can be broadly defined as a faltering of growth from a previously established pattern of growth.",
            "startOffset": 37078,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 50682,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Events that do not meet the case definition should be classified in the additional categories for analysis.",
            "startOffset": 50575,
            "title": "Data analysis"
        },
        {
            "endOffset": 56367,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "It is essential to specify:",
            "startOffset": 56340,
            "title": "Data presentation"
        },
        {
            "endOffset": 24416,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Clinical signs include a loss of subcutaneous fat stores, poor muscle mass, loose skin folds, prominent ribs, thin limbs, sparse hair, rashes, pallor, lethargy, can indicate the level of FTT [23,25,36\u201338].",
            "startOffset": 24211,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 25770,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Indicators used to determine growth are: length/height-for-age; weight-for-age; weight-for-length/height.",
            "startOffset": 25665,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 22735,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Various types of scales are used for weighing young children.",
            "startOffset": 22674,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 40330,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weight obtain using either beam balance or spring balance scale",
            "startOffset": 40267,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 53048,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "The duration of a possible Failure to Thrive could be analysed as the interval between the date/time of onset7 of the first symptoms and/or signs consistent with the definition and the end of episode11 and/or final outcome12.",
            "startOffset": 52823,
            "title": "Data analysis"
        },
        {
            "endOffset": 20155,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In infants aged from birth to 6 months, minimal data exists as to a reliable MUAC for diagnosing SAM.",
            "startOffset": 20054,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 29489,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Multiple general medical, paediatric and infectious disease text books were also searched.",
            "startOffset": 29399,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 53347,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "If more than one measurement of a particular criterion is taken and recorded, the value corresponding to the greatest magnitude of the adverse experience could be used as the basis for analysis.",
            "startOffset": 53153,
            "title": "Data analysis"
        },
        {
            "endOffset": 21188,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "As anthropometric indicators remain the measures of choice in low and high income communities, the working group elected to use weight-for-age as the primary measure.",
            "startOffset": 21022,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 44535,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0060",
            "sentence": "For infants: Gestational age and birth weight.",
            "startOffset": 44489,
            "title": "Demographics"
        },
        {
            "endOffset": 36498,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0025",
            "sentence": "Both were developed to improve data comparability.",
            "startOffset": 36448,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 36852,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0030",
            "sentence": "Validation of this case definition in developed and developing settings should help inform further revision of this case definition.",
            "startOffset": 36720,
            "title": "Periodic review"
        },
        {
            "endOffset": 36447,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0025",
            "sentence": "Neither case definition nor guidelines are intended to guide or establish criteria for management of ill infants, children, or adults.",
            "startOffset": 36313,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 40117,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weight for length less than or equal to the 3rd centile on the appropriate growth chart",
            "startOffset": 40030,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 12599,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "For example, in infants and young children with genetic short stature, prematurity, or intrauterine growth restriction who have an acceptable weight-for-length and normal growth velocity the term FTT is not used [10,11].",
            "startOffset": 12379,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 34571,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Gestation of the baby in weeks should be recorded, and corrected before plotting on growth charts.",
            "startOffset": 34473,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 50574,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Events that meet the case definition should be classified according to the levels of diagnostic certainty as specified in the case definition.",
            "startOffset": 50432,
            "title": "Data analysis"
        },
        {
            "endOffset": 13012,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This phenomenon has also been termed \u201ccatch down\u201d growth [14].",
            "startOffset": 12950,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 19135,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Nutritional indices are calculated by comparing an individual\u2019s measurements with that of a reference population.",
            "startOffset": 19022,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 18558,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The measurement indices of weight and height/length in an equation to calculate a Body Mass Index (BMI) can also be used to identify children that are underweight.",
            "startOffset": 18395,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39262,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weights obtained using a beam balance scale",
            "startOffset": 39219,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 40877,
            "parents": [],
            "secId": "s0035",
            "sentence": "Physical examination consistent with FTT7",
            "startOffset": 40512,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 18092,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This may falsely identify those infants naturally small, such as constitutional low weight while excluding larger infants with inadequate growth and true FTT whose weights do not fall below the lower centiles.",
            "startOffset": 17883,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 20891,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "When only one measurement is available, the diagnosis is based on probabilities and is not definitive without other clinical or laboratory tests.",
            "startOffset": 20746,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 24210,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Physical examination can be used as an indicator for FTT where there are no measurements or are used in combination.",
            "startOffset": 24094,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33577,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "In some settings, it may be impossible to obtain a clear timeline of the event, particularly in less developed or rural settings.",
            "startOffset": 33448,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 41550,
            "parents": [],
            "secId": "s0040",
            "sentence": "However, implementation of all guidelines might not be possible in all settings.",
            "startOffset": 41470,
            "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
        },
        {
            "endOffset": 16004,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This can be due to environmental influences, stimulus deprivation-poverty, feeding techniques, or psychological reasons.",
            "startOffset": 15884,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 22299,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Correct measurement, plotting, and interpretation are essential for identifying growth problems.",
            "startOffset": 22203,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 23023,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In LMIC, the most commonly used in community settings is the hanging spring balance, which can weigh children up to 25 kg.",
            "startOffset": 22901,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 28937,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "All abstracts were screened for possible reports of FTT following immunisation.",
            "startOffset": 28858,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 55487,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "Data should be presented with numerator and denominator (n/N) (and not only in percentages), if available.",
            "startOffset": 55381,
            "title": "Data presentation"
        },
        {
            "endOffset": 21341,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Weight is widely applicable with staff being skilled and most comfortable in measuring weight as a primary tool in all settings throughout LMIC and HIC.",
            "startOffset": 21189,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26850,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "No articles were identified describing FTT as an adverse event following immunisation.",
            "startOffset": 26764,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 29535,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Most publications identified were case series.",
            "startOffset": 29489,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 39928,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weight for age deceleration through at least 2 centile spaces on growth chart",
            "startOffset": 39851,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 29764,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "An inventory comprising nine relevant case definitions of FTT was made available to working group members.",
            "startOffset": 29658,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 52650,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Subjects with Failure to Thrive by Interval to Presentation",
            "startOffset": 52591,
            "title": "Data analysis"
        },
        {
            "endOffset": 40026,
            "parents": [],
            "secId": "s0035",
            "sentence": "Length taken using Infantometer",
            "startOffset": 39995,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 13299,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The term FTT was not used until the 1930s and has evolved to describe under-nutrition resulting in a growth deviation or faltering regardless of the underlying cause.",
            "startOffset": 13133,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 12378,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Among infants, determining FTT presents its own set of challenges.",
            "startOffset": 12312,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 34171,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Constitutional delay in growth: these infants may present with delayed length and occasionally weight compared with their same age peers.",
            "startOffset": 34034,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 34351,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Delayed bone age assessment is helpful above 12 months but is less reliable in infants.",
            "startOffset": 34264,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 58013,
            "parents": [],
            "secId": "s0095",
            "sentence": "They do not necessarily represent the official positions of each participant\u2019s organisation (e.g., government, university, or corporation).",
            "startOffset": 57874,
            "title": "Disclaimer"
        },
        {
            "endOffset": 17882,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "One common way of diagnosing FTT using weight is as a weight less than the third or fifth percentile for age on more than one occasion.",
            "startOffset": 17747,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 24868,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "WHO recommends cutoff values of \u00b12 standard deviations, which correspond to the 2.3rd and 97.7th percentiles (modified to 2nd and 98th percentile) to define abnormal growth [39].",
            "startOffset": 24690,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 34931,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Maternal history of diabetes and parental height and weight information may help identify this condition.",
            "startOffset": 34826,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 56457,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "The method, frequency and duration of monitoring for Failure to Thrive;",
            "startOffset": 56386,
            "title": "Data presentation"
        },
        {
            "endOffset": 26763,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A search for terms describing FTT as adverse event following vaccination identified only articles suggesting immunisation visits as an opportunity for diagnosis of FTT, or under-immunisation being associated with increased risk of FTT [44,45].",
            "startOffset": 26520,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 29924,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "The term failure to thrive",
            "startOffset": 29898,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 16623,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Existing definitions of FTT do not easily distinguish between healthy infants with varied growth patterns and those who truly have FTT.",
            "startOffset": 16488,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 21985,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Accurate, reliable measurements are integral to growth monitoring and the clinical judgments of a child\u2019s growth pattern.",
            "startOffset": 21864,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 55011,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "All reported events of Failure to Thrive should be presented according to the categories listed in guideline 31.",
            "startOffset": 54899,
            "title": "Data presentation"
        },
        {
            "endOffset": 39215,
            "parents": [],
            "secId": "s0035",
            "sentence": "Infant age determined by a documented birth date",
            "startOffset": 39167,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 13133,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Evolution of FTT as a description:",
            "startOffset": 13099,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42336,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0045",
            "sentence": "These guidelines represent a desirable standard for the collection of data on availability following maternal immunisation to allow for comparability of data, and are recommended as an addition to data collected for the specific study question and setting.",
            "startOffset": 42080,
            "title": "Data collection"
        },
        {
            "endOffset": 26520,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Failure to thrive and immunisation: What is known in literature?",
            "startOffset": 26456,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 36719,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0030",
            "sentence": "Similar to all Brighton Collaboration case definitions and guidelines, review of the definition with its guidelines is planned on a regular basis (i.e. every three to five years) or more often if needed.",
            "startOffset": 36516,
            "title": "Periodic review"
        },
        {
            "endOffset": 39991,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weight measured using electronic scale or beam balance scale",
            "startOffset": 39931,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 42062,
            "parents": [],
            "secId": "s0040",
            "sentence": "Also, as explained in more detail in the overview paper in this volume, these guidelines have been developed by this working group for guidance only, and are not to be considered a mandatory requirement for data collection, analysis, or presentation.",
            "startOffset": 41812,
            "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
        },
        {
            "endOffset": 30980,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Differential diagnoses of FTT that may present in infancy include: genetic short stature; constitutional growth delay; \u201cregression to the mean\u201d also known as \u201ccatch down growth\u201d; and preterm infants whose gestational age is not corrected appropriately [14].",
            "startOffset": 30723,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32846,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "For research purposes, the working group elected to focus the case definition on infants.",
            "startOffset": 32757,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 40148,
            "parents": [],
            "secId": "s0035",
            "sentence": "Level 3 of diagnostic certainty",
            "startOffset": 40117,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 14888,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Globally 26 per cent of children under 5 are stunted, however in sub-Saharan Africa and South Asia this number reaches nearer to 40 per cent, while in the most affected countries (Timor-Leste, Burundi, Niger and Madagascar) over 50 per cent of children under 5 are considered stunted [17] Studies show that in some developing countries growth faltering often starts soon after birth.",
            "startOffset": 14505,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32306,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "It is widely agreed that a definition of FTT should be based on anthropometric data, although choice of which variables to use continues to be debated.",
            "startOffset": 32155,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 47944,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Method of measurement (e.g. type of thermometer, oral or other route, duration of measurement, etc.);",
            "startOffset": 47843,
            "title": "The adverse event"
        },
        {
            "endOffset": 22900,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "These also allow the child to be measured in a care givers arms if necessary.",
            "startOffset": 22823,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26353,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "loss of follow-up, usually due to failure to attend clinics",
            "startOffset": 26294,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33447,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Further, FTT often occurs outside the controlled setting of a clinical trial or hospital.",
            "startOffset": 33358,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 21590,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Weight for age below the third or fifth centile does not adequately cover infants with FTT who do not fall to such low weights.",
            "startOffset": 21463,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 19266,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Weight for length: a measure of wasting or acute malnutrition.",
            "startOffset": 19204,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 19823,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It is used for rapid assessments as it identifies wasting and is a globally endorsed selection criteria for entry into selective feeding programs as it is a rapid and effective predictor of risk in children aged 6\u201359 months [30].",
            "startOffset": 19594,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39157,
            "parents": [],
            "secId": "s0035",
            "sentence": "Level 2 of diagnostic certainty",
            "startOffset": 39126,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 56889,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "Comparison group(s), if used for analysis;",
            "startOffset": 56847,
            "title": "Data presentation"
        },
        {
            "endOffset": 57194,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "Whether the date of onset8 and/or the date of first observation9 and/or the date of diagnosis10 was used for analysis; and",
            "startOffset": 57072,
            "title": "Data presentation"
        },
        {
            "endOffset": 52168,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Reported Failure to Thrive with insufficient evidence to meet the case definition17",
            "startOffset": 51873,
            "title": "Data analysis"
        },
        {
            "endOffset": 53652,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Increments specified above should be used.",
            "startOffset": 53610,
            "title": "Data analysis"
        },
        {
            "endOffset": 32756,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "The limited data available on possible FTT post maternal immunisation means a timeframe cannot be determined.",
            "startOffset": 32647,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35566,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Diagnosis of the above differentials should be based on history, examination and further investigations to exclude pathological causes of faltering growth.",
            "startOffset": 35411,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 19404,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Weight for age: a measure of underweight or wasting and stunting combined.",
            "startOffset": 19330,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 19496,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "However, as discussed earlier, faltering length presents later than changes in weight alone.",
            "startOffset": 19404,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26192,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "situations where the child\u2019s age cannot be accurately determined",
            "startOffset": 26128,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26456,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "operational issues and maintenance of measurement equipment to ensure accuracy of measurements [42,43]",
            "startOffset": 26354,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 15114,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In a study in Guatemala, depending on the reference standard used, 19 and 34% of the weight deficit observed in growth-restricted 3 year old children was attributed to failure to thrive during the first 3 months of life [18].",
            "startOffset": 14889,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 10370,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Literature related to defining FTT can be broadly categorized in terms of anthropometric indices, aetiological causes, and a variety of variably interchangeable descriptors used to describe FTT or relevant clinical terms.",
            "startOffset": 10149,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 24617,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The 2006 World Health Organisation (WHO) international growth charts for children <24 months are consistently recommended for use in the assessment of potential FTT.",
            "startOffset": 24452,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 27660,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The proposed case definition will refer only to infants up to 12 months of age.",
            "startOffset": 27581,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 48829,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Exposures other than the immunisation before and after immunisation (e.g. food, environmental) considered potentially relevant to the reported event.",
            "startOffset": 48680,
            "title": "The adverse event"
        },
        {
            "endOffset": 32647,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Specific time frames for onset of symptoms following maternal immunisation are not included for the following main reasons:",
            "startOffset": 32524,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 55992,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "The incidence of cases in the study population should be presented and clearly identified as such in the text.",
            "startOffset": 55882,
            "title": "Data presentation"
        },
        {
            "endOffset": 20053,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "WHO and UNICEF recommend to define severe acute malnutrition (SAM) in infants using of weight for height indicators with the cutoff of below \u22123 standard deviations and a MUAC cut-off point of 115 mm to define SAM with MUAC [5,31].",
            "startOffset": 19823,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39549,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weights obtained using electronic scale",
            "startOffset": 39510,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 56121,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "If the distribution of data is skewed, median and range are usually the more appropriate statistical descriptors than a mean.",
            "startOffset": 55996,
            "title": "Data presentation"
        },
        {
            "endOffset": 13909,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In low income settings, infectious diseases, poverty and inadequate nutrition are the primary risks.",
            "startOffset": 13809,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 51552,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Event classification in 5 categories16",
            "startOffset": 50682,
            "title": "Data analysis"
        },
        {
            "endOffset": 56187,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "However, the mean and standard deviation should also be provided.",
            "startOffset": 56122,
            "title": "Data presentation"
        },
        {
            "endOffset": 19329,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Height for age: a measure of stunting or chronic malnutrition.",
            "startOffset": 19267,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 34033,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Parental height and weight information helps inform this diagnosis.",
            "startOffset": 33966,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 15493,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The community prevalence of FTT in high income countries is reported to be 1\u201310% under 2 years of age, with the United States seeing 5\u201310% of children presenting in primary care settings and 3\u20135% of children in hospital settings [7,20\u201322].",
            "startOffset": 15254,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 22674,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This information can be derived from a known date of birth (such as from birth registration or health cards) or can be based on an estimate derived from a calendar of local events or mother\u2019s recall [30,34].",
            "startOffset": 22467,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 34472,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Preterm infants, if their growth is uncorrected on growth charts for gestation, will grow below the normal growth curve.",
            "startOffset": 34352,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37838,
            "parents": [],
            "secId": "s0035",
            "sentence": "Weights obtained using an electronic scale",
            "startOffset": 37796,
            "title": "Case definition of failure to thrive3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 26127,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "inadequate training of health workers",
            "startOffset": 26090,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 55377,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "Terms to describe Failure to Thrive such as \u201clow-grade\u201d, \u201cmild\u201d, \u201cmoderate\u201d, \u201chigh\u201d, \u201csevere\u201d or \u201csignificant\u201d are highly subjective, prone to wide interpretation, and should be avoided, unless clearly defined.",
            "startOffset": 55167,
            "title": "Data presentation"
        },
        {
            "endOffset": 31085,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Formulating a case definition that reflects diagnostic certainty: Weighing specificity versus sensitivity",
            "startOffset": 30980,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 47842,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Values and units of routinely measured parameters (e.g. temperature, blood pressure) \u2013 in particular those indicating the severity of the event;",
            "startOffset": 47698,
            "title": "The adverse event"
        },
        {
            "endOffset": 10537,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There is no agreed definition and utilisation studies of existing definitions have largely been limited by small sample sizes, apart from two European infant cohorts.",
            "startOffset": 10371,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 17200,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "FTT is consistently evaluated on anthropometrical indicators of weight and length/height.",
            "startOffset": 17111,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 22466,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Age is generally recorded in months.",
            "startOffset": 22430,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26293,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "a child may also be underweight either because of short length/height (stunting) or thinness or both",
            "startOffset": 26193,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 18878,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In low and middle income countries (LMIC) the use of body measurements are used to assess nutritional status.",
            "startOffset": 18769,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 51801,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Level 3: Criteria as specified in the Failure to Thrive case definition",
            "startOffset": 51730,
            "title": "Data analysis"
        },
        {
            "endOffset": 33965,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Genetic short stature: infants born to small parents are typically small from birth and grow along their low percentile for both height and weight, sometimes dipping below their weight centile briefly.",
            "startOffset": 33764,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 53609,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "The distribution of data (as numerator and denominator data) could be analysed in predefined increments (e.g. measured values, times), where applicable.",
            "startOffset": 53457,
            "title": "Data analysis"
        },
        {
            "endOffset": 56799,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "The characteristics of the surveillance system (e.g. population served, mode of report solicitation);",
            "startOffset": 56698,
            "title": "Data presentation"
        },
        {
            "endOffset": 57071,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "Whether the day of immunisation was considered \u201cday one\u201d or \u201cday zero\u201d in the analysis;",
            "startOffset": 56984,
            "title": "Data presentation"
        },
        {
            "endOffset": 57707,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "Use of this case definition for Failure to Thrive, in the abstract or methods section of a publication18,19.",
            "startOffset": 57195,
            "title": "Data presentation"
        },
        {
            "endOffset": 17361,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Weight is the first value affected in a child with FTT, followed by length if the FTT persists.",
            "startOffset": 17266,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 29574,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The terminology was very inconsistent.",
            "startOffset": 29536,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse events following maternal immunisation"
        },
        {
            "endOffset": 33077,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "We postulate that a definition designed to be a suitable tool for testing causal relationships requires ascertainment of the outcome (e.g. FTT) independent from the exposure (e.g. immunisations).",
            "startOffset": 32882,
            "title": "Rationale for selected decisions about the case definition of failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 45415,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                },
                {
                    "id": "s0045",
                    "title": "Data collection"
                },
                {
                    "id": "s0055",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0065",
            "sentence": "(e.g. immunoglobulins, blood transfusion and immunosuppressants).",
            "startOffset": 45350,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 11395,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "FTT is used as a diagnosis, or a description of a weight gain pattern.",
            "startOffset": 11325,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for failure to thrive as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 56633,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0090",
            "sentence": "The trial profile, indicating participant flow during a study including drop-outs and withdrawals to indicate the size and nature of the respective groups under investigation;",
            "startOffset": 56458,
            "title": "Data presentation"
        },
        {
            "endOffset": 51653,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Guidelines for data collection, analysis and presentation of failure to thrive"
                }
            ],
            "secId": "s0085",
            "sentence": "Level 1: Criteria as specified in the Failure to Thrive case definition",
            "startOffset": 51582,
            "title": "Data analysis"
        }
    ],
    "docId": "S0264410X17301160",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Elizabeth",
                "initial": "E.",
                "last": "Ross"
            },
            {
                "email": null,
                "first": "Flor M.",
                "initial": "F.M.",
                "last": "Munoz"
            },
            {
                "email": null,
                "first": "Bassey",
                "initial": "B.",
                "last": "Edem"
            },
            {
                "email": null,
                "first": "Cassandra",
                "initial": "C.",
                "last": "Nan"
            },
            {
                "email": null,
                "first": "Fyezah",
                "initial": "F.",
                "last": "Jehan"
            },
            {
                "email": null,
                "first": "Julie",
                "initial": "J.",
                "last": "Quinn"
            },
            {
                "email": null,
                "first": "Tamala",
                "initial": "T.",
                "last": "Mallett Moore"
            },
            {
                "email": null,
                "first": "Sanie",
                "initial": "S.",
                "last": "Sesay"
            },
            {
                "email": null,
                "first": "Hans",
                "initial": "H.",
                "last": "Spiegel"
            },
            {
                "email": null,
                "first": "Librada",
                "initial": "L.",
                "last": "Fortuna"
            },
            {
                "email": null,
                "first": "Sonali",
                "initial": "S.",
                "last": "Kochhar"
            },
            {
                "email": "contact@brightoncollaboration.org",
                "first": "Jim",
                "initial": "J.",
                "last": "Buttery"
            },
            {
                "email": null,
                "first": null,
                "initial": null,
                "last": null
            }
        ],
        "doi": "10.1016/j.vaccine.2017.01.051",
        "firstpage": "6483",
        "issn": "0264410X",
        "keywords": [
            "Adverse event",
            "Case definition",
            "Failure to thrive",
            "Guidelines",
            "Immunisation",
            "Malnutrition"
        ],
        "lastpage": "6491",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Failure to thrive: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data"
    }
}